Associate Dean, Global Health Sciences
Harold Simon Professor and Chief, Division of Global Public Health, Department of Medicine
University of California San Diego School of Medicine
Adjunct Professor, Johns Hopkins University

Dr. Strathdee is an infectious disease epidemiologist who has spent the last two decades focusing on HIV prevention and the spread of blood-borne pathogens in marginalized populations and access to care, especially among injection drug users and sex workers. In the last decade, she has published more than 350 peer-reviewed articles on HIV prevention and the natural history of HIV and related infections. Dr. Strathdee received her PhD in Epidemiology in 1994 from the University of Toronto, after completing a Bachelor of Science in Microbiology and a Master of Science in Epidemiology. Prior to her appointment at Johns Hopkins, she was an Assistant Professor in the Department of Health Care and Epidemiology at the University of British Columbia, and Program Director of Epidemiology at the British Columbia Centre for Excellence in HIV/AIDS. Her research on risk behaviours in injection drug users earned Dr. Strathdee the International Young Investigators Award in Epidemiology, presented by the XI International Conference on AIDS held in Vancouver in 1996, after which time she was named a National Health Scholar by the National Health Research Development Program of Health Canada. She was named one of the "100 Canadians to Watch" by Maclean's magazine in 1997. The Financial Post also named her one of the "Top 40 Under 40" in 1998. Dr. Strathdee also leads three NIH-funded studies of HIV risk behaviours among drug users and sex workers on the Mexico-US border, directs a Fogarty-funded Global Health Program Frameworks grant and has led a binational USAID-funded cross-border HIV prevention training program partnership between academic institutions in San Diego and Tijuana. Dr. Strathdee currently holds six research grants from the National Institute on Drug Abuse and the Centers for Disease Control, funding from which exceeds US$15 million.